EUTOS for CML

EUTOS for CML is a unique collaboration between the European LeukemiaNet and Novartis Oncology in Europe

News

2010/03/24:
eCRF-System available online

2009/11/17:
Updated pocked card now available here

Events
Fr 2010/10/22 - Su 2010/10/24 New benchmarks in leukemia: Focus on CML, AML and MDS The following questions, as well as other complex issues, will be discussed in the programme of the ELN Frontiers Meeting···

The EUropean Treatment Outcome Study (EUTOS) is a collaboration between the European LeukemiaNet ELN and Novartis to improve understanding of CML, promote best practise, and enhance treatment outcomes, through 4 key projects:

CML registry
Molecular monitoring
Pharmacologic monitoring
Spread of excellence.

Major aims of the alliance are, to:

Enhance understanding of the nature and management of CML
Improve standardized evaluation and monitoring of treatments for CML
Optimize treatment of CML patients across Europe

Created by: A. Hellenbrecht , generated 2007/12/19 , last changed: 2008/07/23